[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

GB201009097D0 - Compounds for the treatment of clostridium difficile-associated disease - Google Patents

Compounds for the treatment of clostridium difficile-associated disease

Info

Publication number
GB201009097D0
GB201009097D0 GBGB1009097.5A GB201009097A GB201009097D0 GB 201009097 D0 GB201009097 D0 GB 201009097D0 GB 201009097 A GB201009097 A GB 201009097A GB 201009097 D0 GB201009097 D0 GB 201009097D0
Authority
GB
United Kingdom
Prior art keywords
compounds
treatment
associated disease
clostridium difficile
difficile
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1009097.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Summit Therapeutics Ltd
Original Assignee
Summit Corp PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Summit Corp PLC filed Critical Summit Corp PLC
Priority to GBGB1009097.5A priority Critical patent/GB201009097D0/en
Publication of GB201009097D0 publication Critical patent/GB201009097D0/en
Priority to SI201130790A priority patent/SI2575968T1/en
Priority to EP11728027.1A priority patent/EP2575968B1/en
Priority to CA2801274A priority patent/CA2801274C/en
Priority to DK11728027.1T priority patent/DK2575968T3/en
Priority to EP15190275.6A priority patent/EP3011960B1/en
Priority to PCT/GB2011/000831 priority patent/WO2011151621A1/en
Priority to PT117280271T priority patent/PT2575968E/en
Priority to JP2013512984A priority patent/JP5845502B2/en
Priority to AU2011260097A priority patent/AU2011260097B2/en
Priority to PL11728027T priority patent/PL2575968T3/en
Priority to ES15190275T priority patent/ES2803556T3/en
Priority to ES11728027.1T priority patent/ES2568455T3/en
Priority to RU2012157571/04A priority patent/RU2575477C2/en
Priority to RS20160310A priority patent/RS54781B1/en
Priority to CN201180037073.2A priority patent/CN103025383B/en
Priority to HUE11728027A priority patent/HUE028746T2/en
Priority to BR112012030621-9A priority patent/BR112012030621B1/en
Priority to US13/691,319 priority patent/US8987308B2/en
Priority to HK13104684.8A priority patent/HK1177706A1/en
Priority to HK16111340.6A priority patent/HK1223032A1/en
Priority to US14/620,902 priority patent/US9278091B2/en
Priority to JP2015090826A priority patent/JP6150841B2/en
Priority to US15/011,185 priority patent/US20170217983A2/en
Priority to HRP20160397TT priority patent/HRP20160397T1/en
Priority to CY20161100379T priority patent/CY1117671T1/en
Priority to SM201600260T priority patent/SMT201600260B/en
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
GBGB1009097.5A 2010-06-01 2010-06-01 Compounds for the treatment of clostridium difficile-associated disease Ceased GB201009097D0 (en)

Priority Applications (27)

Application Number Priority Date Filing Date Title
GBGB1009097.5A GB201009097D0 (en) 2010-06-01 2010-06-01 Compounds for the treatment of clostridium difficile-associated disease
BR112012030621-9A BR112012030621B1 (en) 2010-06-01 2011-06-01 compounds for the treatment of disease associated with clostridium difficile
ES11728027.1T ES2568455T3 (en) 2010-06-01 2011-06-01 Compounds for the treatment of Clostridium difficile-associated disease
RS20160310A RS54781B1 (en) 2010-06-01 2011-06-01 Compounds for the treatment of clostridium difficile associated disease
CA2801274A CA2801274C (en) 2010-06-01 2011-06-01 Compounds for the treatment of clostridium difficile-associated disease
DK11728027.1T DK2575968T3 (en) 2010-06-01 2011-06-01 COMPOUNDS FOR THE TREATMENT OF Clostridium difficile-associated disease
EP15190275.6A EP3011960B1 (en) 2010-06-01 2011-06-01 Compounds for the treatment of clostridium difficile-associated disease
PCT/GB2011/000831 WO2011151621A1 (en) 2010-06-01 2011-06-01 Compounds for the treatment of clostridium difficile associated disease
PT117280271T PT2575968E (en) 2010-06-01 2011-06-01 Compounds for the treatment of clostridium difficile associated disease
JP2013512984A JP5845502B2 (en) 2010-06-01 2011-06-01 Compounds for treating Clostridium difficile-related diseases
AU2011260097A AU2011260097B2 (en) 2010-06-01 2011-06-01 Compounds for the treatment of clostridium difficile associated disease
PL11728027T PL2575968T3 (en) 2010-06-01 2011-06-01 Compounds for the treatment of clostridium difficile associated disease
ES15190275T ES2803556T3 (en) 2010-06-01 2011-06-01 Compounds for the treatment of diseases associated with clostridium difficile
SI201130790A SI2575968T1 (en) 2010-06-01 2011-06-01 Compounds for the treatment of clostridium difficile associated disease
RU2012157571/04A RU2575477C2 (en) 2010-06-01 2011-06-01 Compounds for treating clostridium difficile associated diseases
EP11728027.1A EP2575968B1 (en) 2010-06-01 2011-06-01 Compounds for the treatment of clostridium difficile associated disease
CN201180037073.2A CN103025383B (en) 2010-06-01 2011-06-01 Compounds for the treatment of clostridium difficile associated disease
HUE11728027A HUE028746T2 (en) 2010-06-01 2011-06-01 Compounds for the treatment of clostridium difficile associated disease
US13/691,319 US8987308B2 (en) 2010-06-01 2012-11-30 Compounds for the treatment of Clostridium difficile-associated disease
HK13104684.8A HK1177706A1 (en) 2010-06-01 2013-04-17 Compounds for the treatment of clostridium difficile associated disease
HK16111340.6A HK1223032A1 (en) 2010-06-01 2013-04-17 Compounds for the treatment of clostridium difficile associated disease
US14/620,902 US9278091B2 (en) 2010-06-01 2015-02-12 Compounds for the treatment of Clostridium difficile associated disease
JP2015090826A JP6150841B2 (en) 2010-06-01 2015-04-27 Compounds for treating Clostridium difficile-related diseases
US15/011,185 US20170217983A2 (en) 2010-06-01 2016-01-29 Compounds for the treatment of clostridium difficile associated disease
HRP20160397TT HRP20160397T1 (en) 2010-06-01 2016-04-18 Compounds for the treatment of clostridium difficile associated disease
CY20161100379T CY1117671T1 (en) 2010-06-01 2016-05-06 CLOSTRIDIUM DIFFICILE COMPLICATIONS FOR THERAPEUTIC DISEASE TREATMENT
SM201600260T SMT201600260B (en) 2010-06-01 2016-08-03 COMPOUNDS FOR TREATING A DISEASE ASSOCIATED WITH A DIFFICULT CLOSTRIDIUM

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1009097.5A GB201009097D0 (en) 2010-06-01 2010-06-01 Compounds for the treatment of clostridium difficile-associated disease

Publications (1)

Publication Number Publication Date
GB201009097D0 true GB201009097D0 (en) 2010-07-14

Family

ID=42371262

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1009097.5A Ceased GB201009097D0 (en) 2010-06-01 2010-06-01 Compounds for the treatment of clostridium difficile-associated disease

Country Status (1)

Country Link
GB (1) GB201009097D0 (en)

Similar Documents

Publication Publication Date Title
ZA201403795B (en) Formulations for the treatment of diabetes
EP2558493A4 (en) Antibodies for the treatment of clostridium difficile-associated infection and disease
HRP20160397T1 (en) Compounds for the treatment of clostridium difficile associated disease
GB201021103D0 (en) New compounds for the treatment of neurodegenerative diseases
EP2654745A4 (en) Composition for the treatment of skin conditions
EP2621498A4 (en) Combination treatment for dermatological conditions
SG2014014724A (en) METHODS FOR THE TREATMENT OF IL-1ß RELATED CONDITIONS
EP2521569A4 (en) Combined treatment utilizing vb-201
PL2548439T3 (en) Plant disease control agent
SI2605764T1 (en) Compositions for the treatment of cancer
IL222479A (en) Methods for tissue engineering
EP2544686A4 (en) Combination methods for treatment of disease
EP2536436A4 (en) Antimir-451 for the treatment of polycythemias
EP2582410A4 (en) Methods for complex tissue engineering
EP2556161A4 (en) Methods for the treatment of autoimmune diseases
EP2601954A4 (en) Therapeutic agent for disease
GB201013060D0 (en) Compounds for the treatment of clostridium difficile associated disease
GB201009091D0 (en) Compounds for the treatment of clostridium difficile-associated disease
GB201013058D0 (en) Compounds for the treatment of clostridium difficile associated disease
GB201009108D0 (en) Compounds for the treatment of clostridium difficile associated disease
GB201009090D0 (en) Compounds for the treatment of clostridium difficile associated disease
GB201009085D0 (en) Compounds for the treatment of clostridium difficile associated disease
GB201009097D0 (en) Compounds for the treatment of clostridium difficile-associated disease
GB201009095D0 (en) Compounds for the treatment of clostridium difficile-associated disease
GB201106972D0 (en) Compounds for the treatment of clostridium difficile-associated disease

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)